Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
patritumab deruxtecan
×
30 days
×
Clear all
Filters
3
NCT06445972
2026-03-16
MK-3475-06D
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
210 enrolled
NCT06469944
2026-03-16
MK-3475-06C
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
160 enrolled